13F-HR filed by Krensavage Asset Management, LLC
Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-13, with 23 holding rows worth $219,568,000.
- Accession
- 0001609251-15-000002
- Filer
- CIK 1609251
- Filed
- 2015-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2015
A holdings report, 23 entries on the cover page, a total value of $219,568,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $219,568,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 130,801 | $22,555,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 410,944 | $19,261,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 341,091 | $18,644,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 248,200 | $15,463,000 | thousands by filing date | |
| HALYARD HEALTH INC | 40650V100 | COM | 304,150 | $14,964,000 | thousands by filing date | |
| SUCAMPO PHARMACEUTICALS-CL A | 864909106 | CL A | 933,866 | $14,531,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 424,016 | $12,983,000 | thousands by filing date | |
| CONMED CORP COM | 207410101 | Stock | 251,274 | $12,687,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 209,304 | $12,031,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 309,698 | $11,115,000 | thousands by filing date | |
| HILL ROM HLDGS INC | 431475102 | COM | 188,327 | $9,228,000 | thousands by filing date | |
| AMGEN INC. | 31162100 | COM | 57,000 | $9,111,000 | thousands by filing date | The CUSIP as filed is malformed. |
| RTI BIOLOGICS INC | 74975N105 | COM | 1,701,458 | $8,405,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 343,546 | $7,699,000 | thousands by filing date | |
| ACTAVIS PLC | G0083B108 | SHS | 21,954 | $6,534,000 | thousands by filing date | |
| INVACARE CORP | 461203101 | COMMON STOCK | 334,762 | $6,498,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 70,000 | $4,098,000 | thousands by filing date | |
| BIOTA HOLDINGS LTD | 90694100 | COM | 1,356,652 | $3,120,000 | thousands by filing date | The CUSIP as filed is malformed. |
| INDIVIOR PLC ORD | G4766E108 | Common Stock | 1,000,000 | $2,817,000 | thousands by filing date | |
| THERAVANCE INC | 88338T104 | COMMON STOCK | 161,188 | $2,534,000 | thousands by filing date | |
| COLUMBIA LABS INC | 197779200 | COM NEW | 316,149 | $1,963,000 | thousands by filing date | |
| DIGIRAD CORP | 253827109 | COM | 419,604 | $1,905,000 | thousands by filing date | |
| FURIEX PHARMACEUTICALS | 36106P101 | COM | 145,544 | $1,422,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001609251-15-000002 | this filing | 2015-05-13 | acceptance time not in the bulk data set |